151 related articles for article (PubMed ID: 18632417)
1. Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan.
Huang YC; Yeh JH; Chiu HC; Chen WH
J Formos Med Assoc; 2008 Jul; 107(7):572-5. PubMed ID: 18632417
[TBL] [Abstract][Full Text] [Related]
2. Age at sampling and sex distribution of AChRAb vs. MuSKAb myasthenia gravis in a large Greek population.
Belimezi M; Kalliaropoulos A; Jiménez J; Garcia I; Mentis AA; Chrousos GP
Clin Neurol Neurosurg; 2021 Sep; 208():106847. PubMed ID: 34343914
[TBL] [Abstract][Full Text] [Related]
3. Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.
Muppidi S; Wolfe GI
Front Neurol Neurosci; 2009; 26():109-119. PubMed ID: 19349708
[TBL] [Abstract][Full Text] [Related]
4. MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis.
Yeh JH; Chen WH; Chiu HC; Bai CH
J Neurol Sci; 2007 Dec; 263(1-2):191-3. PubMed ID: 17602704
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
Sanadze AG; Sidnev DV; Karganov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
Yeh JH; Chen WH; Chiu HC; Vincent A
Neurology; 2004 Jun; 62(11):2131-2. PubMed ID: 15184635
[No Abstract] [Full Text] [Related]
7. MuSK-antibody-positive myasthenia gravis in a South Asian population.
Chang T; Gunaratne P; Gamage R; Riffsy MT; Vincent A
J Neurol Sci; 2009 Sep; 284(1-2):33-5. PubMed ID: 19394052
[TBL] [Abstract][Full Text] [Related]
8. Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population.
Chang T; Leite MI; Senanayake S; Gunaratne PS; Gamage R; Riffsy MT; Jacobson LW; Adhikari M; Perera S; Vincent A
J Neurol Sci; 2014 Aug; 343(1-2):82-7. PubMed ID: 24929651
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.
Witoonpanich R; Dejthevaporn C; Pulkes T; Tunlayadechanont S; Boonkongchuen P; Pongpakdee S; Vincent A
J Clin Neurosci; 2013 May; 20(5):707-9. PubMed ID: 23352351
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis patients with anti-MuSK antibodies.
Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
[TBL] [Abstract][Full Text] [Related]
11. Muscle-specific receptor tyrosine kinase autoantibodies--a new immunoprecipitation assay.
Matthews I; Chen S; Hewer R; McGrath V; Furmaniak J; Rees Smith B
Clin Chim Acta; 2004 Oct; 348(1-2):95-9. PubMed ID: 15369741
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in Japanese patients with ocular myasthenia gravis.
Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H
Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484
[TBL] [Abstract][Full Text] [Related]
13. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
14. [Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis].
Konishi T; Kousaka M; Yamakawa K; Matsui M; Ohta K
Rinsho Shinkeigaku; 2009 Oct; 49(10):660-3. PubMed ID: 19999149
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
16. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
17. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
18. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
[TBL] [Abstract][Full Text] [Related]
20. [Seronegative myasthenia gravis].
Gajdos P
Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
